scholarly journals Human Parvovirus B19 Infection Among Blood Donors in North-East of Iran

2020 ◽  
Vol 15 (4) ◽  
Author(s):  
Ameneh Karimnia ◽  
Ameneh Elikaei ◽  
Zohreh Sharifi

Background: Human parvovirus B19 is a single-stranded DNA and non-enveloped virus which belongs to the Parvoviridae family. The virus spreads through respiratory secretions and perinatal blood. B19 may cause serious complications in patients with cellular immunodeficiency that have no detectable antibodies to B19, such as aplastic crises in solid organs. Objectives: The present study aimed to investigate the prevalence of parvovirus B19 and to evaluate the presence of B19 DNA among blood donors in Golestan Province. Methods: Sera of 400 blood donors in Golestan Province who were negative for HIV, HbsAg, and HCV were tested for both IgG and IgM anti-B19 virus antibodies using the ELISA method, following which all sera were tested for the presence of B19 DNA by semi-nested PCR. Results: 242 (out of 400) subjects (60.5%; 95% CI) were positive for anti-B19 IgG, and 158 were negative for IgG antibody (39.5%; 95% CI). Moreover, all asymptomatic blood donors were negative for anti-B19 IgM. No viral genome was found in serum samples of donors. Conclusions: Since no viral genome was found in the donors' serum samples and the relatively high prevalence of anti HPV- B19 IgG in blood donors, it can be concluded that the possibility of B19 transmission through blood transfusion is low. However, special caution should be taken when transfusing blood to the high-risk groups such as pregnant women, immune-deficient patients, and those with hematological problems, particularly regarding IgG anti- HPV- B19 antibodies (HPV- B19-safe).

Author(s):  
Jussara P. Nascimento ◽  
Marie M. Buckley ◽  
Kevin E. Brown ◽  
Bernard J. Cohen

During 1985 and 1986 serum samples were collected from the Rio de Janeiro population and examined for the presence of IgG antibody to human parvovirus B19. No difference in prevalence was found between males and females. Antibody prevalence rose from 35% in children less than five years old to almost 80% in children aged eleven to fifteen years. The antibody prevalence in individuals over 50 years old was over 90%.


Transfusion ◽  
2008 ◽  
Vol 48 (5) ◽  
pp. 1036-1037 ◽  
Author(s):  
Harumichi Matsukura ◽  
Sachiko Shibata ◽  
Yoshihiko Tani ◽  
Hirotoshi Shibata ◽  
Rika A. Furuta

2017 ◽  
Vol 232 ◽  
pp. 134-138 ◽  
Author(s):  
Huanzhou Xu ◽  
Sujuan Hao ◽  
Junmei Zhang ◽  
Zhen Chen ◽  
Hanzhong Wang ◽  
...  

Vox Sanguinis ◽  
1995 ◽  
Vol 69 (3) ◽  
pp. 206-212 ◽  
Author(s):  
M. Tsujimura ◽  
K. Matsushita ◽  
H. Shiraki ◽  
H. Sato ◽  
K. Okochi ◽  
...  

2017 ◽  
Vol 63 (3) ◽  
pp. 224-228 ◽  
Author(s):  
Maria Isabel de Oliveira ◽  
Ana Maria Sardinha Afonso ◽  
Suely Pires Curti ◽  
Patrícia Evelin Silva ◽  
Tamyris Fernanda Barbosa ◽  
...  

Summary Introduction: Virus surveillance strategies and genetic characterization of human parvovirus B19 (B19V) are important tools for regional and global control of viral outbreak. In São Paulo, Brazil, we performed a study of B19V by monitoring the spread of this virus, which is an infectious agent and could be mistakenly reported as a rash and other types of infection. Method: Serum samples were subjected to enzyme immunoassay, real time polymerase chain reaction, and sequencing. Results: From the 462 patients with suspected cases of exanthematic infections, the results of the 164 serum samples were positive for B19V immunoglobulin M. Among these cases, there were 38 patients with erythema infections and B19-associated with other infections such as encephalitis, hydrops fetalis, chronic anemia, hematological malignancies. These samples were sequenced and identified as genotype 1. Conclusion: This study showed patients with infections caused by B19V and sequencing genotype 1. Continuous monitoring is necessary to detect all known genotypes, and the emergence of new genotypes of these viruses for case management in public health control activities.


2013 ◽  
Vol 69 (3) ◽  
pp. 268-272 ◽  
Author(s):  
Satish Kumar ◽  
R.M. Gupta ◽  
Sourav Sen ◽  
R.S. Sarkar ◽  
J. Philip ◽  
...  

2013 ◽  
Vol 7 (12) ◽  
pp. 946-950 ◽  
Author(s):  
Iyanda Abiodun ◽  
Oluyinka Oladele Opaleye ◽  
Olusola Ojurongbe ◽  
Ademola Hezekiah Fagbami

Introduction: Human parvovirus B19 causes a wide range of complications in pregnant women including abortion, severe fetal anemia, non-immune hydrops fetalis, and even intrauterine fetal death. However, there is a dearth of information on the prevalence of the virus among pregnant women in southwestern Nigeria. Methodology: Blood samples were collected from 231 pregnant women and screened for antibodies to human parvovirus B19 IgM and IgG using an enzyme immunosorbent assay kits. Results: Of the 231 women, 31 were in their first trimester, 146 were in their second trimester, and 54 were in their third trimester. Forty-five (20%) were positive for parvovirus B19 IgG antibodies, 10 (4%) were positive for parvovirus B19 IgM antibodies, and 176 (76%) had no detectable parvovirus B19 antibodies. Twenty-eight (19%) of the 146 pregnant women in their second trimester were positive for parvovirus B19 IgG antibody while three (2%) of the 146 were positive for parvovirus B19 IgM antibody. Conclusions: It is evident that there is a high prevalence of human parvovirus B19 among pregnant women in south-western Nigeria. This suggests that there is an active transmission of the virus in the community; it is therefore necessary to conduct more studies on the virus in pregnant women in Nigeria to ascertain its effect on the fetus.


2021 ◽  
Vol 8 (1) ◽  
pp. 34-38
Author(s):  
Eissa Soleymani ◽  
Afshin Azimi ◽  
Fariba Faizi ◽  
Shirafkan Kordi ◽  
Mazaher Azorde ◽  
...  

Background: Toxoplasmosis is a worldwide infection caused by Toxoplasma gondii, an obligate intracellular protozoan. It infects approximately one-third of the world’s population. This study was conducted to determine the anti-T. gondii antibodies (IgG and IgM) in the rural population of Qaemshahr, northern Iran, in 2019. Methods: Serum samples of 350 individuals referred to the laboratories of the rural health centers in Qaemshahr, northern Iran, were collected from February to April 2019 and were assessed for anti-T. gondii antibodies (IgG and IgM) using the ELISA kits (Pishtazteb, Iran). The results were analyzed using the chi-square test. Results: Totally, 296 (84.57%, 95% CI: 80.07%-88.2%) out of 350 serum samples were positive for anti-T. gondii IgG antibody. There was a significant correlation between seropositivity of anti-T. gondii IgG antibody and age (P=0.000), contact with soil (P=0.000), and job. None of the samples were positive for anti-T. gondii IgM antibody. No significant association was observed between the seroprevalence of T. gondii and the gender, contact with the cat and other animals, and ingestion of undercooked meat, non-chlorinated water, undercooked egg, raw milk and vegetables. Conclusions: Results of the study showed that the prevalence of toxoplasmosis was much higher among the rural individuals in Qaemshahr, northern Iran, than those previously reported from other areas of Iran. Therefore, efforts should be focused on public health education to reduce the risk of toxoplasmosis transmission especially in the high-risk groups in this region.


Sign in / Sign up

Export Citation Format

Share Document